D. E. Shaw & Co., Inc. - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,253,316
+19.1%
114,458
+44.0%
0.00%0.0%
Q2 2023$1,052,342
+6.4%
79,482
+9.4%
0.00%0.0%
Q1 2023$988,984
-24.4%
72,666
+8.4%
0.00%0.0%
Q4 2022$1,308,764
-19.9%
67,013
-21.8%
0.00%
-50.0%
Q3 2022$1,633,000
+133.0%
85,745
+152.1%
0.00%
+100.0%
Q2 2022$701,000
+164.5%
34,006
+339.2%
0.00%
Q1 2021$265,000
+31.2%
7,742
+29.4%
0.00%
Q4 2020$202,0005,9830.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders